Gemmer Asset Management LLC Zoetis Inc. Transaction History

Gemmer Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$155.97 - $200.09 $43,515 - $55,825	-279 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$181.39 - $234.03 $5,985 - $7,722	-33 Reduced 10.58%	279 $52,000
Q2 2021 Jul 23, 2021	BUY	$155.9 - $187.99 $1,559 - $1,879	10 Added 3.31%	312 $58,000
Q4 2020 Jan 28, 2021	SELL	$157.07 - $174.35 $4,869 - $5,404	-31 Reduced 9.31%	302 $50,000
Q4 2019 Jan 17, 2020	SELL	$116.25 - $133.25 $2,906 - $3,331	-25 Reduced 6.98%	333 $44,000

Q2 2019 Jul 18, 2019	BUY	$97.98 - $114.28 $19,596 - $22,856	200 Added 126.58%	358 $41,000
Q3 2017 Oct 12, 2017	BUY	$59.73 - $65.4 $9,437 - $10,333	158	158 $10,000

1,860

419M

1.13M

1.82M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.